Lead Capital Partners has made a strategic investment in Lieberman, Inc., a primary market research firm, aiming to leverage its expertise in healthcare services to drive growth and innovation.

Information on the Target

Lieberman, Inc. ("Lieberman" or the "Company"), founded in 1981, is a leading primary market research and analytics firm that caters to a diverse clientele, with a strong emphasis on the pharmaceutical, healthcare, and consumer sectors. The Company specializes in conducting both quantitative and qualitative research through direct interaction with physicians, patients, and consumers. Leveraging proprietary tools and methodologies, Lieberman provides customized insights in areas such as attitude and usage tracking, brand health assessment, brand positioning, competitive intelligence, patient journey mapping, product and pricing strategy, and market segmentation. The existing management team will remain in place post-investment to ensure continuity in operations and strategy.

Karl LiVigni, Partner at Lieberman, expressed that the partnership with Lead Capital Partners ("LCP") signifies a significant opportunity for the Company. He noted that LCP's alignment with Lieberman's culture and values, along with their proven ability to foster enduring partnerships, will facilitate the Company's growth while upholding its commitment to providing exceptional services to clients.

Industry Overview in the Target’s Specific Country

The healthcare services industry in the United States has seen considerable growth over the past decade, driven by factors such as an aging population, advances in medical technology, and increasing demand for hea